The article mentions, Gilead licensed 11 companies in India to make generics. I don't see how licensing to make generics make it stealing intellectual property.
Besides I am curious how $1000 in USA compares to $4 (about ₹ 265) with the per capita income in perspective, as a measure of affordability of the drug.